Résumés
Résumé
Les tendons contiennent une grande proportion de matrice extracellulaire mais peu de cellules et de vaisseaux sanguins. Par conséquent, le processus physiologique menant à la réparation du tendon lésé dure plus longtemps que pour la plupart des autres tissus. Certains traitements empiriques sont actuellement appliqués dans le but d’accélérer le processus de réparation. Ces approches dogmatiques reposent fortement sur la prémisse selon laquelle l’inflammation est néfaste et sur le fait que les anti-inflammatoires non stéroïdiens (AINS) sont à prescrire durant la phase inflammatoire aiguë ou chronique. Cependant, des données récentes démontrent que certains médiateurs de la réponse inflammatoire sont essentiels à l’organisation du processus de réparation tissulaire. Cet article analysera donc la pluralité des rôles des prostaglandines et les effets des AINS lors des différentes phases du processus de réparation.
Summary
Tendons are extracellular matrix rich structures allowing the transmission of forces generated by skeletal muscles to bones in order to produce movements. Some intrinsic characteristics of tendons, namely hypovascularity and hypocellularity, may explain their slow rate of healing. A growing body of evidence suggests that the inflammatory process, essential for pathogen clearance and injury scavenging, may play opposite functions in tendon healing. For instance, inflammation can lead to degradation of intact collagen and to viable cell death, thereby increasing the functional deficit and recovery period. Paradoxically, many cellular and subcellular events occurring during the inflammatory response lead to the release of a plethora of growth factors that trigger the healing phase. Prostaglandins are implicated in the inflammatory process and may also contribute to the primary steps of tendon healing. Prolonged administration of non steroidal anti-inflammatory drugs (NSAIDs) is a common practice following musculoskeletal injuries. However, there is no clear consensus on the effect of NSAIDs on tendon healing. This review presents a contemporary vision of the inflammatory process following tendon injury and examines the roles of the constitutive and inducible COX-derived prostaglandins. The effect of COX inhibitors will be addressed and special attention will be taken to describe COX-independent effects of these pharmacological inhibitors. Together, this review is an attempt to guide readers toward a more conscientious use of NSAIDs following tendon injuries.
Parties annexes
Références
- 1. Nguyen HX, Tidball JG. Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J Physiol 2003 ; 547 : 125-32.
- 2. Galleron S, Borderie D, Ponteziere C, et al. Reactive oxygen species induce apoptosis of synoviocytes in vitro. Alpha-tocopherol provides no protection. Cell Biol Int 1999 ; 23 : 637-42.
- 3. Yuan J, Murrell GA, Trickett A, et al. Involvement of cytochrome c release and caspase-3 activation in the oxidative stress-induced apoptosis in human tendon fibroblasts. Biochim Biophys Acta 2003 ; 1641 : 35-41.
- 4. Maeda H, Okamoto T, Akaike T. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 1998 ; 379 : 193-200.
- 5. Lee W, Aitken S, Sodek J, et al. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo : role of active enzyme in human periodontitis. J Periodontal Res 1995 ; 30 : 23-33.
- 6. Van de Louw A, Jean D, Frisdal E, et al. Neutrophil proteinases in hydrochloric acid- and endotoxin-induced acute lung injury : evaluation of interstitial protease activity by in situ zymography. Lab Invest 2002 ; 82 : 133-45.
- 7. Langberg H, Rosendal L, Kjaer M. Training-induced changes in peritendinous type I collagen turnover determined by microdialysis in humans. J Physiol 2001 ; 534 : 297-302.
- 8. Choi HR, Kondo S, Hirose K, et al. Expression and enzymatic activity of MMP-2 during healing process of the acute supraspinatus tendon tear in rabbits. J Orthop Res 2002 ; 20 : 927-33.
- 9. Nabeshima Y, Grood ES, Sakurai A, et al. Uniaxial tension inhibits tendon collagen degradation by collagenase in vitro. J Orthop Res 1996 ; 14 : 123-30.
- 10. Marsolais D, Côté CH, Frenette J. Nonsteroidal anti-inflammatory drug reduces neutrophil and macrophage accumulation but does not improve tendon regeneration. Lab Invest 2003 ; 83 : 991-9.
- 11. Ward C, Dransfield I, Murray J, et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J Immunol 2002 ; 168 : 6232-43.
- 12. Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998 ; 101 : 890-8.
- 13. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF- beta1 secretion and the resolution of inflammation. J Clin Invest 2002 ; 109 : 41-50.
- 14. Gilroy DW, Colville-Nash PR, Willis D, et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999 ; 5 : 698-701.
- 15. Reddy SM, Hsiao KH, Abernethy VE, et al. Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation : activation of Akt and inhibition of extracellular signal- regulated kinases 1 and 2. J Immunol 2002 ; 169 : 702-13.
- 16. Marsolais D, Côté CH, Frenette J. Neutrophils and macrophages accumulate sequentially following Achilles tendon injury. J Orthop Res 2001 ; 19 : 1203-9.
- 17. Enwemeka CS. Inflammation, cellularity, and fibrillogenesis in regenerating tendon : implications for tendon rehabilitation. Phys Ther 1989 ; 69 : 816-25.
- 18. Mazzone MF, McCue T. Common conditions of the Achilles tendon. Am Fam Physician 2002 ; 65 : 1805-10.
- 19. Dahners LE, Gilbert JA, Lester GE, et al. The effect of a nonsteroidal antiinflammatory drug on the healing of ligaments. Am J Sports Med 1988 ; 16 : 641-6.
- 20. Elder CL, Dahners LE, Weinhold PS. A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. Am J Sports Med 2001 ; 29 : 801-5.
- 21. Kampfer H, Brautigam L, Geisslinger G, et al. Cyclooxygenase-1-coupled prostaglandin biosynthesis constitutes an essential prerequisite for skin repair. J Invest Dermatol 2003 ; 120 : 880-90.
- 22. Wallace JL, Bak A, McKnight W, et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice : implications for gastrointestinal toxicity. Gastroenterology 1998 ; 115 : 101-9.
- 23. Iniguez MA, Rodriguez A, Volpert OV, et al. Cyclooxygenase-2 : a therapeutic target in angiogenesis. Trends Mol Med 2003 ; 9 : 73-8.
- 24. Lapointe BM, Frémont P, Côté CH. Adaptation to lengthening contractions is independent of voluntary muscle recruitment but relies on inflammation. Am J Physiol Regul Integr Comp Physiol 2002 ; 282 : R323-9.
- 25. Riley GP, Cox M, Harrall RL, et al. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro.J Hand Surg Br 2001 ; 26 : 224-8.
- 26. Almekinders LC, Baynes AJ, Bracey LW. An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts. Am J Sports Med 1995 ; 23 : 119-23.
- 27. Diaz-Gonzalez F, Gonzalez-Alvaro I, Campanero MR, et al. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J Clin Invest 1995 ; 95 : 1756-65.
- 28. Kothari HV, Lee WH, Ku EC. An alternate mechanism for regulation of leukotriene production in leukocytes : studies with an anti-inflammatory drug, sodium diclofenac. Biochim Biophys Acta 1987 ; 921 : 502-11.
- 29. Locatelli L, Sacerdote P, Mantegazza P, et al. Effect of ibuprofen and diclofenac on the chemotaxis induced by substance P and transforming growth factor-beta on human monocytes and polymorphonuclear cells. Int J Immunopharmacol 1993 ; 15 : 833-8.
- 30. Clish CB, Sun YP, Serhan CN. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors : NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase. Biochem Biophys Res Commun 2001 ; 288 : 868-74.